All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drfrancogomez on Instagram · 68s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @drfrancogomez's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I'm absolutely sorry about this project
  2. 0:13and I'll talk to you about the project
  3. 0:20They know people don't make a game that's made.
  4. 0:25I'm sure if the game is like a flicker,
  5. 0:38I'll make a flicker with a flicker,
  6. 0:40but if they want to,
  7. 0:42I can play some games,
  8. 0:44and I will do one last week to help the players,
  9. 0:47so if I have to do a flicker then I will try.
  10. 0:50It's a good game for a flicker,
  11. 0:52and I'll show you how to play,
  12. 0:54because this is a game they want to play.
  13. 0:57And it will make it very difficult to play it,
  14. 1:00and if you have any questions, please leave them in the comments.

@drfrancogomez's GHK-Cu 'youth peptide' claims, fact-checked

Dr. Franco Gómez Dermatólogo B.A 🇦🇷

Instagram creator

27.6K viewsView on Instagram

Quick answer

The caption claims GHK-Cu stimulates collagen and elastin and reduces wrinkles, claims that have in vitro and limited small-scale human support but lack robust RCT evidence in humans. The actual spoken transcript was unintelligible and could not be evaluated for clinical content, meaning the only verifiable claims originate from the written caption alone. GHK-Cu is not FDA-approved as a drug for any dermatological indication, and compounded injectable formulations carry uncharacterized safety and efficacy profiles distinct from topical cosmetic use.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksGHK-Cu (Copper Peptide)Provider discussion

Evidence signal

Source-backed review

Regulatory reality

GHK-Cu (Copper Peptide) access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drfrancogomez's GHK-Cu 'youth peptide' claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this ghk-cu video claims cluster

Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@drfrancogomez's GHK-Cu 'youth peptide' claims, fact-checked" from Dr. Franco Gómez Dermatólogo B.A 🇦🇷. We read the clip as a Peptide social video fact-checks claim about GHK-Cu (Copper Peptide), then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The caption claims GHK-Cu stimulates collagen and elastin and reduces wrinkles, claims that have in vitro and limited small-scale human support but lack robust RCT evidence in humans.

The reason this review is not generic is the source wording and the canonical claim label "peptides descubr el poder del ghk cu conocido como el p ptid." In this clip, the useful excerpt is: "I'm absolutely sorry about this project and I'll talk to you about the project They know people don't make a game that's made." That wording changes the review because it points to GHK-Cu (Copper Peptide) safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. GHK-Cu (Copper Peptide) still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

In vitro collagen stimulation by GHK-Cu is well-documented in fibroblast studies, but cell-dish results do not automatically translate to visible human skin outcomes.
People who land here are usually comparing the GHK-Cu (Copper Peptide) claim with GHKCu, peptides, and peptide.
The strongest next step is to compare the claim with FormBlends' GHK-Cu (Copper Peptide) guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The caption claims GHK-Cu stimulates collagen and elastin and reduces wrinkles, claims that have in vitro and limited small-scale human support but lack robust RCT evidence in humans.

FormBlends verdict

GHK-Cu (Copper Peptide) safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The caption claims GHK-Cu stimulates collagen and elastin and reduces wrinkles, claims that have in vitro and limited small-scale human support but lack robust RCT evidence in humans. The actual spoken transcript was unintelligible and could not be evaluated for clinical content, meaning the only verifiable claims originate from the written caption alone. GHK-Cu is not FDA-approved as a drug for any dermatological indication, and compounded injectable formulations carry uncharacterized safety and efficacy profiles distinct from topical cosmetic use.
  • GHK-Cu plasma levels do decline with age, from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60 (Pickart, 1973, Nature), which is the legitimate biological basis for anti-aging interest.
  • In vitro collagen stimulation by GHK-Cu is well-documented in fibroblast studies, but cell-dish results do not automatically translate to visible human skin outcomes.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.

Review GHK-Cu (Copper Peptide)

What You'll Learn

  • GHK-Cu plasma levels do decline with age, from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60 (Pickart, 1973, Nature), which is the legitimate biological basis for anti-aging interest.
  • In vitro collagen stimulation by GHK-Cu is well-documented in fibroblast studies, but cell-dish results do not automatically translate to visible human skin outcomes.
  • The only human cosmetic trial frequently cited (Leyden et al., 2009) was small, short-term, and industry-funded, making its conclusions preliminary at best.
  • GHK-Cu is not FDA-approved as a drug for wrinkles or any skin condition. Topical versions are sold as cosmetics, which face lower evidence requirements than drugs.
  • Compounded injectable GHK-Cu operates outside the evidence base used to support the caption's cosmetic claims, and purity and systemic safety data in humans are not well established.
  • The spoken transcript in this video was incoherent and unrelated to the topic, meaning viewers were informed only by the caption, not by any actual medical explanation from the creator.
  • If you're evaluating GHK-Cu seriously, look for randomized controlled trials with vehicle controls and independent funding. As of current literature, those barely exist.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drfrancogomez actually say?

Here's the uncomfortable truth: the transcript attached to this video is gibberish. The audio-to-text capture produced something about games and flickering, which has nothing to do with GHK-Cu or skin aging. What we can evaluate comes entirely from the caption, which claims GHK-Cu is a "revolution in aesthetic medicine," stimulates collagen and elastin production, reduces expression lines, and improves skin firmness. That's the content we're fact-checking, because that's what 27,600 people likely absorbed.

The caption frames GHK-Cu as the "peptide of youth," a marketing phrase that carries more hype than clinical weight. The claims are specific enough to evaluate: collagen stimulation, elastin production, wrinkle reduction, and improved firmness. These are testable assertions, and the literature does have something to say about them.

Does the science back this up?

Partially, yes, but mostly in lab dishes and rodent studies, not robust human clinical trials. That gap matters more than any peptide evangelist will tell you.

GHK-Cu (copper tripeptide-1) has a legitimate research trail. Pickart and Margolina (2018, Cosmetics) reviewed decades of work showing GHK-Cu activates genes related to collagen synthesis, wound repair, and anti-inflammatory pathways. In vitro studies consistently show fibroblast stimulation. A study by Finkley et al. (1997, Journal of Biomaterials Science) found increased collagen synthesis in human fibroblast cultures treated with GHK-Cu. Those are real findings.

The problem is the leap from cell cultures to "revolution in dermatology." Human randomized controlled trials on topical or injectable GHK-Cu are thin. A small study by Leyden et al. (2009, Journal of Cosmetic Dermatology) found modest improvements in fine lines with a GHK-Cu-containing cream versus vehicle, but sample sizes were small and industry-funded. That's not a revolution. That's a preliminary signal worth watching.

What did they get wrong (or right)?

Credit where it's due: the collagen and elastin angle isn't fabricated. The mechanism has biological plausibility. GHK-Cu does appear to upregulate matrix metalloproteinases and growth factors involved in skin remodeling. Pickart's research group has documented this across multiple papers spanning 30 years.

What's wrong is the certainty. Calling GHK-Cu a "true revolution" sets expectations that the clinical evidence cannot support. There are no large-scale phase III trials establishing GHK-Cu as a proven anti-aging treatment in humans. The FDA has not cleared any GHK-Cu product for wrinkle treatment as a drug. Compounded injectable versions circulating in wellness spaces carry additional unknowns around purity, dosing, and systemic effects that the caption completely ignores.

There's also no mention of limitations: skin penetration barriers for topical use, the difference between injectable and cosmetic applications, or the fact that most dramatic results in photos involve confounding variables like lighting, hydration, and concurrent skincare. Omitting all of that while calling something a revolution is misleading, even if the individual mechanism claims have partial support.

What should you actually know?

GHK-Cu is a naturally occurring peptide in human plasma, and its concentrations do decline with age, dropping from roughly 200 ng/mL at age 20 to around 80 ng/mL by age 60, according to Pickart (1973, Nature). That age-related decline is the biological hook behind anti-aging interest, and it's real data.

What's less clear is whether supplementing GHK-Cu topically or systemically meaningfully reverses that decline in a way that produces visible, lasting skin changes in humans at safe concentrations. Topical peptides face real absorption challenges. Injectable GHK-Cu in compounded form is used in some longevity clinics, but it operates outside the evidence base that supports any specific cosmetic outcome claim.

If you're interested in peptide-based skincare, the honest answer is that GHK-Cu is one of the more scientifically grounded options compared to many cosmetic peptides, but "more grounded than the noise" is a low bar. Talk to a board-certified dermatologist before adding any compounded peptide to your routine, especially injectables.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Franco Gómez Dermatólogo B.A 🇦🇷 · Instagram creator

27.6K views on this video

¡Descubrí el poder del GHK-Cu! 🧪✨ Conocido como el “péptido de la juventud”, este compuesto es una verdadera revolución en la medicina estética y la dermatología. Su capacidad para estimular la prod

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu plasma levels do decline with age, from roughly 200?

GHK-Cu plasma levels do decline with age, from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60 (Pickart, 1973, Nature), which is the legitimate biological basis for anti-aging interest.

What does the video say about in vitro collagen stimulation by ghk-cu?

In vitro collagen stimulation by GHK-Cu is well-documented in fibroblast studies, but cell-dish results do not automatically translate to visible human skin outcomes.

What does the video say about the only human cosmetic trial frequently cited (leyden et al.,?

The only human cosmetic trial frequently cited (Leyden et al., 2009) was small, short-term, and industry-funded, making its conclusions preliminary at best.

What does the video say about ghk-cu?

GHK-Cu is not FDA-approved as a drug for wrinkles or any skin condition. Topical versions are sold as cosmetics, which face lower evidence requirements than drugs.

What does the video say about compounded injectable ghk-cu operates outside the evidence base used to?

Compounded injectable GHK-Cu operates outside the evidence base used to support the caption's cosmetic claims, and purity and systemic safety data in humans are not well established.

What does the video say about the spoken transcript in this video was incoherent?

The spoken transcript in this video was incoherent and unrelated to the topic, meaning viewers were informed only by the caption, not by any actual medical explanation from the creator.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Franco Gómez Dermatólogo B.A 🇦🇷, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.